{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:52:36Z","timestamp":1782921156491,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["RS-2023-00219399"],"award-info":[{"award-number":["RS-2023-00219399"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003662","name":"Korea Evaluation Institute of Industrial Technology","doi-asserted-by":"publisher","award":["20020237"],"award-info":[{"award-number":["20020237"]}],"id":[{"id":"10.13039\/501100003662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2023-00210964"],"award-info":[{"award-number":["RS-2023-00210964"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jconrel.2024.06.061","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:44:44Z","timestamp":1719953084000},"page":"699-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Genetically engineered long-acting Esculentin-2CHa(1\u221230) fusion protein with potential applicability for the treatment of NAFLD"],"prefix":"10.1016","volume":"372","author":[{"given":"Jaewoong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeju","family":"Amatya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunmi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krismala","family":"Djayanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Ah","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu Seob","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meong Cheol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.06.061_bb0005","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cld.1045","article-title":"Nonalcoholic fatty liver disease and recent guideline updates","volume":"17","author":"Ando","year":"2021","journal-title":"Clin. Liver Disease"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus\u2014mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4093\/dmj.2019.0011","article-title":"Nonalcoholic fatty liver disease in diabetes. Part I: epidemiology and diagnosis","volume":"43","author":"Lee","year":"2019","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0035","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/14789450.2019.1693894","article-title":"Peptidomic analysis in the discovery of therapeutically valuable peptides in amphibian skin secretions","volume":"16","author":"Conlon","year":"2019","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/toxins12050313","article-title":"Drug delivery strategies for enhancing the therapeutic efficacy of toxin-derived anti-diabetic peptides","volume":"12","author":"Amatya","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0045","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.peptides.2011.01.018","article-title":"Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona","volume":"32","author":"Conlon","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/JOE-16-0453","article-title":"Esculentin-2CHa (1\u201330) and its analogues: stability and mechanisms of insulinotropic action","volume":"232","author":"Vasu","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141549","article-title":"Esculentin-2CHa-related peptides modulate islet cell function and improve glucose tolerance in mice with diet-induced obesity and insulin resistance","volume":"10","author":"Ojo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.peptides.2012.11.004","article-title":"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells","volume":"39","author":"Attoub","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0065","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00726-017-2469-3","article-title":"Anti-diabetic actions of esculentin-2CHa (1\u201330) and its stable analogues in a diet-induced model of obesity-diabetes","volume":"49","author":"Vasu","year":"2017","journal-title":"Amino Acids"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0070","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.apsb.2021.05.002","article-title":"A review of existing strategies for designing long-acting parenteral formulations: focus on underlying mechanisms, and future perspectives","volume":"11","author":"Shi","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0075","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/cmdc.201600374","article-title":"Half-life extension of biopharmaceuticals using chemical methods: alternatives to PEGylation","volume":"11","author":"van Witteloostuijn","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0080","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1097-2765(01)00230-1","article-title":"Crystal structure at 2.8 \u00c5 of an FcRn\/heterodimeric fc complex: mechanism of pH-dependent binding","volume":"7","author":"Martin","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0085","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2015.02.005","article-title":"The neonatal fc receptor, FcRn, as a target for drug delivery and therapy","volume":"91","author":"Sockolosky","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0014-5793(95)01452-7","article-title":"The serum albumin-binding domain of streptococcal protein G is a three-helical bundle: a heteronuclear NMR study","volume":"378","author":"Kraulis","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/protein\/gzv040","article-title":"Fusion to a highly stable consensus albumin binding domain allows for tunable pharmacokinetics","volume":"28","author":"Jacobs","year":"2015","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120250","article-title":"Genetic engineering of novel super long-acting Exendin-4 chimeric protein for effective treatment of metabolic and cognitive complications of obesity","volume":"257","author":"Lee","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40005-022-00585-9","article-title":"Tumor-originated pH-responsive nanovaccine mixture to treat heterogeneous tumors","volume":"52","author":"Park","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40005-022-00574-y","article-title":"Alginate-coated chitosan nanoparticles protect protein drugs from acid degradation in gastric media","volume":"52","author":"Tran","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1021\/tx500479m","article-title":"Nanotoxicity of silver nanoparticles to red blood cells: size dependent adsorption, uptake, and hemolytic activity","volume":"28","author":"Chen","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0125","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00401058","article-title":"Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets","volume":"36","author":"Ishihara","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0130","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0140","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s001250050822","article-title":"NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X","volume":"40","author":"Pickup","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.iy.07.040189.003205","article-title":"The biology of cachectin\/TNF--a primary mediator of the host response","volume":"7","author":"Beutler","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0150","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0160","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1021\/cr4006704","article-title":"The chemistry and biological activities of peptides from amphibian skin secretions","volume":"115","author":"Xu","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0165","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/1751-7915.14213","article-title":"Structure\u2013activity relationships of antibacterial peptides","volume":"16","author":"Ciulla","year":"2023","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0170","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol"},{"key":"10.1016\/j.jconrel.2024.06.061_bb0175","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A role of peroxisome proliferator-activated receptor \u03b3 in non-alcoholic fatty liver disease","volume":"124","author":"Skat-R\u00f8rdam","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2024.06.061_bb0180","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/liv.14205","article-title":"Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion","volume":"39","author":"Eriksen","year":"2019","journal-title":"Liver Int."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T11:09:26Z","timestamp":1728299366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924004218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":36,"alternative-id":["S0168365924004218"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.061","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically engineered long-acting Esculentin-2CHa(1\u221230) fusion protein with potential applicability for the treatment of NAFLD","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}